Archive

Financial figures for the acquisition were undisclosed

Is indicated for the treatment of schizophrenia, and for the treatment of acute manic episodes associated with bipolar disorder

Expects to generate a cumulative revenue of $20 million within five years of the launch

Otsuka’s phase III clinical trials for delamanid are now underway

Announces launch of drugs in breast cancer and colo-rectal cancer segment

Helperby will supply Cadila Pharmaceuticals with antibiotic resistance breakers

The drug is a first in the class active immunotherapy as well as drug targeting Desmocollin-3

Will focus on engagement, quality, big-data, and payment transformation driven by US health reform

Lupin has received final approval for its Abacavir Sulfate, Lamivudine, and Zidovudine Tablets, 300 mg (base) / 150 mg / 300 mg…

Glenmark Generics, USA, the subsidiary of Glenmark Generics, has launched Hydrocortisone Butyrate cream USP, 0.1 per cent in the…